Recent progress in multiple sclerosis treatment using immune cells as targets

HIGHLIGHTS

• who: Xiaohong Ma and colleagues from the Department of Neuroscience, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China have published the paper: Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets, in the Journal: Pharmaceutics 2023, 15, 728. of /2023/
• what: The study showed that EAE mice have elevated levels of Th17 cells and IL-17, and that the risk of EAE infection was significantly reduced when Th17 cells were reduced or when IL-6 and IL-23 were lacking .
• how: In two identical phase III trials . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.